For following the competition: what moved in each program, several studies read as one move.
- KRAS G12D Inhibitor VS-7375
- GFH276
- GFS202A
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Genfleet Therapeutics (Shanghai) to watchlistEvery Monday by email · turn it off any timePro · free during the beta